Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiformeSzu‐Ting Chou, Julia Y. Ljubimova, Pallavi R. Gangalum et al.|Journal of Controlled Release|2016Cited by 51
HER2-positive breast cancer targeting and treatment by a peptide-conjugated mini nanodrugHui Ding, Eggehard Holler, Pallavi R. Gangalum et al.|Nanomedicine Nanotechnology Biology and Medicine|2016Cited by 40